How Many People Work at Novavax? Headcount and Employee Trends

Novavax is a biotechnology company focused on developing and commercializing vaccines. The organization employs roughly 850 people, with 21 recent additions and 102 departures that signal ongoing adjustments to its staffing needs. Its talent strategy supports research, regulatory affairs, manufacturing, and corporate operations needed to advance vaccine programs. The headcount distribution underscores the multidisciplinary nature of bringing biologics from the lab to market.

Engineering is the company’s largest team at 217 employees, reflecting the technical resources required for process development and manufacturing. Business Management (103) and Operations (98) round out the next-largest groups, providing program oversight and day-to-day production support. Finance & Administration (76) and Sales & Support (69) supply the financial controls and customer-facing expertise needed to commercialize products, while specialized areas such as Healthcare, Risk & Compliance, Quality, and Marketing & Product collectively account for more than 180 professionals. Overall hiring of 21 employees and 102 departures were spread across these functions, indicating selective expansion and realignment rather than broad-based growth.

Employee locations show a strong Mid-Atlantic footprint. Roughly one in six team members work in Washington, DC (139), and Gaithersburg, MD (98) hosts a significant contingent near the company’s headquarters and R&D facilities. Additional clusters are found in Rockville, Frederick, Germantown, and Bethesda, illustrating the concentration of life-science talent along the I-270 biotechnology corridor. Smaller groups operate in New York, Philadelphia, Chicago, and other locations, while 462 employees are classified under “Other,” a category that captures remote staff and international sites supporting global clinical and commercial activities.